Non-opioid pain drug development is finally turning a corner. With Vertex’s recent approval paving the way, the field is entering a new era–one defined by safer, more effective treatments for ...
The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results